Yearly intrasubject variability of hematological biomarkers in elite athletes for the Athlete Biological Passport

IF 2.6 3区 医学 Q2 BIOCHEMICAL RESEARCH METHODS
Bastien Krumm, Carsten Lundby, Joar Hansen, Jacob Bejder, Henrik Sørensen, Tristan Equey, Jonas Saugy, Francesco Botrè, Raphael Faiss
{"title":"Yearly intrasubject variability of hematological biomarkers in elite athletes for the Athlete Biological Passport","authors":"Bastien Krumm,&nbsp;Carsten Lundby,&nbsp;Joar Hansen,&nbsp;Jacob Bejder,&nbsp;Henrik Sørensen,&nbsp;Tristan Equey,&nbsp;Jonas Saugy,&nbsp;Francesco Botrè,&nbsp;Raphael Faiss","doi":"10.1002/dta.3645","DOIUrl":null,"url":null,"abstract":"<p>Confounding factors including exercise and environments challenge the interpretation of individual Athlete Biological Passports (ABPs). This study aimed to investigate the natural variability of hematological ABP parameters over 1 year in elite athletes compared with healthy control subjects and the validity of a multiparametric model estimating plasma volume (PV) shifts to correct individual ABP thresholds. Blood samples were collected monthly with full blood counts performed by flow cytometry (Sysmex XN analyzers) in 20 elite xc-skiers (ELITE) and 20 moderately trained controls. Individual ABP profiles were generated through Anti-Doping Administration &amp; Management System Training, a standalone version of the ABP's adaptive model developed by the World Anti-Doping Agency. Additionally, eight serum parameters were computed as volume-sensitive biomarkers to run a multiparametric model to estimate PV. Variability in ELITE compared with controls was significantly higher for the Abnormal Blood Profile Scores (<i>P</i> = 0.003). Among 12 Atypical Passport Findings (ATPF) initially reported, six could be removed after correction of PV shifts with the multiparametric modeling. However, several ATPF were additionally generated (<i>n =</i> 19). Our study outlines a larger intraindividual variability in elite athletes, likely explained by more frequent exposure to extrinsic factors altering hematological biomarkers. PV correction for individual ABP thresholds allowed to explain most of the atypical findings while generating multiple new ATPF occurrences in the elite population. Overall, accounting for PV shifts in elite athletes was shown to be paramount in this study outlining the opportunity to consider PV variations with novel approaches when interpreting individual ABP profiles.</p>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":"16 11","pages":"1285-1294"},"PeriodicalIF":2.6000,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dta.3645","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Testing and Analysis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/dta.3645","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Confounding factors including exercise and environments challenge the interpretation of individual Athlete Biological Passports (ABPs). This study aimed to investigate the natural variability of hematological ABP parameters over 1 year in elite athletes compared with healthy control subjects and the validity of a multiparametric model estimating plasma volume (PV) shifts to correct individual ABP thresholds. Blood samples were collected monthly with full blood counts performed by flow cytometry (Sysmex XN analyzers) in 20 elite xc-skiers (ELITE) and 20 moderately trained controls. Individual ABP profiles were generated through Anti-Doping Administration & Management System Training, a standalone version of the ABP's adaptive model developed by the World Anti-Doping Agency. Additionally, eight serum parameters were computed as volume-sensitive biomarkers to run a multiparametric model to estimate PV. Variability in ELITE compared with controls was significantly higher for the Abnormal Blood Profile Scores (P = 0.003). Among 12 Atypical Passport Findings (ATPF) initially reported, six could be removed after correction of PV shifts with the multiparametric modeling. However, several ATPF were additionally generated (n = 19). Our study outlines a larger intraindividual variability in elite athletes, likely explained by more frequent exposure to extrinsic factors altering hematological biomarkers. PV correction for individual ABP thresholds allowed to explain most of the atypical findings while generating multiple new ATPF occurrences in the elite population. Overall, accounting for PV shifts in elite athletes was shown to be paramount in this study outlining the opportunity to consider PV variations with novel approaches when interpreting individual ABP profiles.

Abstract Image

Abstract Image

运动员生物护照中精英运动员血液生物标志物的年度受试者内变异性。
包括运动和环境在内的干扰因素对运动员个人生物护照(ABPs)的解释提出了挑战。本研究旨在调查精英运动员与健康对照组相比一年内血液学 ABP 参数的自然变异性,以及估算血浆容量(PV)变化的多参数模型对校正个体 ABP 阈值的有效性。每月采集 20 名优秀越野滑雪运动员(ELITE)和 20 名训练适中的对照组运动员的血样,并通过流式细胞仪(Sysmex XN 分析仪)进行全血细胞计数。个人 ABP 档案通过反兴奋剂管理与管理系统培训生成,该系统是世界反兴奋剂机构开发的 ABP 适应模型的独立版本。此外,还计算了 8 个血清参数作为体积敏感生物标志物,以运行多参数模型来估算 PV。与对照组相比,ELITE 的异常血液特征评分的变异性明显更高(P = 0.003)。在最初报告的 12 个非典型护照结果 (ATPF) 中,有 6 个在使用多参数模型校正 PV 变异后可以去除。然而,又产生了几个 ATPF(n = 19)。我们的研究概述了精英运动员更大的个体内变异性,这可能是由于更频繁地暴露于改变血液生物标志物的外在因素所致。对个体 ABP 阈值进行 PV 校正可解释大多数非典型发现,同时在精英人群中产生多个新的 ATPF。总之,在这项研究中,对精英运动员的血压变化进行考虑是至关重要的,这说明在解释个人 ABP 资料时,有机会以新颖的方法考虑血压变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Testing and Analysis
Drug Testing and Analysis BIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL
CiteScore
5.90
自引率
24.10%
发文量
191
审稿时长
2.3 months
期刊介绍: As the incidence of drugs escalates in 21st century living, their detection and analysis have become increasingly important. Sport, the workplace, crime investigation, homeland security, the pharmaceutical industry and the environment are just some of the high profile arenas in which analytical testing has provided an important investigative tool for uncovering the presence of extraneous substances. In addition to the usual publishing fare of primary research articles, case reports and letters, Drug Testing and Analysis offers a unique combination of; ‘How to’ material such as ‘Tutorials’ and ‘Reviews’, Speculative pieces (‘Commentaries’ and ‘Perspectives'', providing a broader scientific and social context to the aspects of analytical testing), ‘Annual banned substance reviews’ (delivering a critical evaluation of the methods used in the characterization of established and newly outlawed compounds). Rather than focus on the application of a single technique, Drug Testing and Analysis employs a unique multidisciplinary approach to the field of controversial compound determination. Papers discussing chromatography, mass spectrometry, immunological approaches, 1D/2D gel electrophoresis, to name just a few select methods, are welcomed where their application is related to any of the six key topics listed below.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信